Canonic
Biotechnology - Heidelberg, Baden-Wurttemberg, Germany
Canonic Details
Canonic is a subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), developing medical Cannabis products through a Computational Predictive Biology (CPB) platform. The company's products in development are aimed at improving active compounds yield, genetic stability and Cannabis varieties for specific medical indications. The company's strategy includes the development of Cannabis varieties in order to commercialize medical Cannabis products independently or through collaborations. Canonic has exclusive access to Evogene's genomic assets and technology for the development of medical Cannabis products. For more information, please visit: https://www.canonicbio.com/
Canonic Technologies
CMS
WordPress.org
Tag Management
Google Tag Manager
Online Video Platforms
Vimeo
Other
Mobile Friendly